✨
AI Summary
- Dr. Peter Marks discusses FDA's CBER innovation areas.
- Recommendations for streamlined FDA engagement and manufacturing.
- Advice for companies navigating clinical development and regulatory pathways.
Guests on This Episode
PM
Peter Marks
2 podcast appearances